MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.imlet.2020.09.002

Медицинская библиотека · Immunology letters · 2020

Successful DAA therapy for chronic hepatitis C reduces HLA-DR on monocytes and circulating immune mediators: A long-term follow-up study.

Rosário Natalia Fonseca, Saraiva Geórgia do Nascimento, Medeiros Thalia, Gandini Mariana, Lacerda Gilmar, Leite Paulo Emílio Corrêa, Andrade Thaís Guaraná, Azeredo Elzinandes Leal, Xavier Analúcia Rampazzo, Silva Andrea Alice

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

INTRODUCTION

After DAA treatment for chronic hepatitis C infection, peripheral monocyte subsets from patients who achieved sustained virological response (SVR) reduced compared to healthy control. Improvement in inflammatory parameters and liver stiffness has been observed. However, little is known about the long-term impact of DAA treatment on peripheral monocyte subsets and immune mediators levels.

OBJECTIVES

We aimed to examine peripheral monocyte subsets and immune mediators levels in Brazilian chronic HCV patients after long-term successful IFN-free SOF-based treatment.

MATERIAL AND

METHODS

We analyzed CD14++CD16-, CD14++CD16+ and CD14+CD16++ monocytes and 27 immune mediators by flow cytometry and analysis of multiple secreted proteins assay, respectively, in monoinfected chronic HCV patients receiving IFN-free sofosbuvir-based regimens followed before treatment, at SVR and one year after the end of treatment (1y).

RESULTS

Twenty-one biomarkers decreased significantly at 1y and 55-80 % of patients this reduction at 1y. Experimented patients presented a greater modulation of immune mediators at 1y. HLA-DR expression significantly decreased on CD14++CD16- and CD14++CD16+ monocytes at 1y when compared to SVR.

CONCLUSIONS

Successful DAA therapy did not modify monocyte subsets frequency but reduced monocyte activation at 1y and sustained the downregulation and restoration of circulating immune mediators, indicating that long-term reversal of inflammation status could occur after HCV eradication.

Для цитирования: Rosário Natalia Fonseca, Saraiva Geórgia do Nascimento, Medeiros Thalia, Gandini Mariana, Lacerda Gilmar, Leite Paulo Emílio Corrêa, Andrade Thaís Guaraná, Azeredo Elzinandes Leal, Xavier Analúcia Rampazzo, Silva Andrea Alice. Successful DAA therapy for chronic hepatitis C reduces HLA-DR on monocytes and circulating immune mediators: A long-term follow-up study.. Immunology letters. 2020. DOI: 10.1016/j.imlet.2020.09.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.